"The Effect of AI-Assisted Mobilization Education on Kinesiophobia and Readiness for Hospital Discharge in Patients Undergoing Total Knee Arthroplasty''

July 4, 2026 updated by: Berru Erseçkin, Kocaeli University

The aim of this study is to investigate the effect of artificial intelligence-assisted mobilization education provided to patients undergoing total knee arthroplasty on their level of kinesiophobia and readiness for hospital discharge.

The research questions are as follows:

Does artificial intelligence-assisted mobilization education provided to patients undergoing total knee arthroplasty affect their level of kinesiophobia? Does artificial intelligence-assisted mobilization education provided to patients undergoing total knee arthroplasty affect their readiness for hospital discharge? Study Procedure In the control group, participants will receive the standard care routinely provided in the orthopedic clinic, without viewing the artificial intelligence-assisted mobilization education video. In the intervention group, participants will receive an artificial intelligence-assisted video-based mobilization education program developed to prepare them for their first postoperative mobilization.

Intervention Group:

After hospital admission, participants will complete a Personal Information Form. On postoperative day 1, before the first mobilization, the Tampa Scale for Kinesiophobia will be administered. Following completion of the baseline assessment, participants will receive the artificial intelligence-assisted video-based mobilization education delivered by a nurse. Immediately after the education, the Tampa Scale for Kinesiophobia will be administered again. Four hours before hospital discharge, participants will complete the Readiness for Hospital Discharge Scale-Patient Self-Assessment Form, and the nurse will complete the Readiness for Hospital Discharge Scale for Adult Patients-Nurse Assessment Short Form.

Control Group:

After hospital admission, participants will complete a Personal Information Form. On postoperative day 1, before the first mobilization, the Tampa Scale for Kinesiophobia will be administered. Following the baseline assessment, participants will receive the routine verbal mobilization education provided by the nurse. Immediately after the education, the Tampa Scale for Kinesiophobia will be administered again. Four hours before hospital discharge, participants will complete the Readiness for Hospital Discharge Scale-Patient Self-Assessment Form, and the nurse will complete the Readiness for Hospital Discharge Scale for Adult Patients-Nurse Assessment Short Form.

At the final stage of the study, all preoperative and postoperative data collected from the participants will be compiled, recorded, and analyzed.

Inclusion Criteria:

Patients will be included in the study if they meet the following criteria:

Age 18 years or older Undergoing total knee arthroplasty for the first time Able to read and write in Turkish No impairments that would prevent watching, hearing, or understanding the educational video No diagnosed psychiatric disorders and not using psychiatric medications that may affect the accuracy of responses No additional conditions affecting mobility other than knee arthroplasty No administration of narcotic analgesics within 30-60 minutes prior to mobilization Having access to a mobile phone capable of viewing the educational video during both the preoperative and postoperative periods.

The population of the study will consist of all patients undergoing total knee arthroplasty in the Orthopedics Clinic of a state hospital. The sample will include patients who meet the study eligibility criteria and agree to participate in the study. A total of 72 patients will participate in the study, with 36 patients assigned to the control group and 36 patients assigned to the intervention group. Written and verbal informed consent will be obtained from all patients prior to participation in the study.

Data will be analyzed using SPSS version 25.0 (Statistical Package for the Social Sciences).

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Total knee arthroplasty (TKA) is one of the most effective surgical treatments for patients with advanced knee osteoarthritis. Early postoperative mobilization is essential for reducing complications, improving functional recovery, increasing patient independence, and facilitating a safe hospital discharge. However, many patients experience kinesiophobia after surgery, which may negatively affect their participation in rehabilitation and delay recovery. Innovative educational approaches, including artificial intelligence (AI)-assisted education, may improve patients' understanding of postoperative mobilization and increase their confidence in performing recommended activities.

The purpose of this study is to evaluate the effect of AI-assisted mobilization education on kinesiophobia and readiness for hospital discharge in patients undergoing total knee arthroplasty.

This is a non-randomized controlled interventional study involving 72 adult patients scheduled to undergo primary total knee arthroplasty. Participants will be allocated to either the intervention group (n=36) or the control group (n=36). The control group will receive the routine perioperative education and standard nursing care provided by the orthopedic clinic. In addition to routine care, the intervention group will receive AI-assisted mobilization education designed to support postoperative recovery and encourage early mobilization.

Data will be collected using a Patient Information Form, the Tampa Scale for Kinesiophobia, the Readiness for Hospital Discharge Scale-Patient Self-Assessment Form, and the Readiness for Hospital Discharge Scale-Nurse Assessment Form for Adult Patients. Assessments will be performed on the first postoperative day and approximately four hours before hospital discharge.

The primary objective of the study is to determine whether AI-assisted mobilization education reduces kinesiophobia and improves patients' readiness for hospital discharge compared with routine care. The findings are expected to contribute to the development of evidence-based educational interventions that enhance postoperative recovery and discharge preparation for patients undergoing total knee arthroplasty.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
72

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Willing to participate in the study voluntarily,
  • Aged 18 years or older,
  • Undergoing primary total knee arthroplasty for the first time,
  • Able to read and write in Turkish,
  • Having no visual, hearing, or cognitive impairment that would prevent watching, hearing, or understanding the educational video,
  • Having no psychiatric disorder or use of psychiatric medication that could interfere with providing accurate responses to the study questionnaires, Having no other condition, apart from the indication for total knee arthroplasty, that affects mobility,
  • Not having received narcotic analgesia within 30-60 minutes before mobilization,
  • Having access to a mobile phone on which the educat

Exclusion Criteria:

  • Patients who are immobile or have restricted mobility,
  • Patients undergoing revision surgery or those who have undergone concomitant orthopedic surgery or orthopedic surgery within the previous month,
  • Patients with impaired consciousness,
  • Patients who decline to participate in the study,
  • Patients with visual, hearing, or cognitive impairment,
  • Patients who develop a postoperative complication resulting in restricted mobility,
  • Patients with any condition that limits mobilization (e.g., amputation, paralysis, etc.)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
No Intervention: 1.Control Group - Standard Mobilization Education
Experimental: Intervention Group - AI-Assisted Video-Based Mobilization Education
Other: Artificial intelligence-assisted mobilization education video
Participants in the intervention group will receive an artificial intelligence-assisted video-based mobilization education program designed to prepare them for postoperative mobilization after total knee arthroplasty. The educational video will be delivered by a nurse on postoperative day 1 prior to the first mobilization. The content of the video includes information and guidance on safe mobilization techniques following surgery. Kinesiophobia levels will be assessed using the Tampa Scale for Kinesiophobia before and immediately after the intervention. In addition, readiness for hospital discharge will be evaluated prior to discharge using the Readiness for Hospital Discharge Scale.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Effect of AI-Assisted Mobilization Education on Kinesiophobia Change in Kinesiophobia
Time Frame: Postoperative day1, immediately before and after mobilization education.
Kinesiophobia will be assessed using the Tampa Scale for Kinesiophobia (TSK). The TSK is a validated questionnaire used to measure fear of movement and reinjury. Higher scores indicate greater levels of kinesiophobia.
Postoperative day1, immediately before and after mobilization education.

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Effect of AI-Assisted Mobilization Education on Readiness for Hospital Discharge Readiness for Hospital Discharge
Time Frame: Within 4 hours before hospital discharge.
The effect of AI-assisted mobilization education on readiness for hospital discharge will be evaluated using the Readiness for Hospital Discharge Scale-Patient Self-Assessment Form.
Within 4 hours before hospital discharge.
Effect of AI-Assisted Mobilization Education on Readiness for hospital Discharge Readiness for hospital Discharge
Time Frame: Within 4 hours before hospital discharge
The effect of AI-Assisted Mobilization Education on Readiness for hospital Discharge will be evaluated using the Readiness for Hospital Discharge Scale-Nurse Self- Assesment Form
Within 4 hours before hospital discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Kocaeli University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
May 5, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
October 1, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
October 30, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
June 29, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 4, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
July 10, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
July 10, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 4, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
July 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 2025/24/38

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings